BioNeutral Group, Inc. (OTCBB: BONU) (OTCQB: BONU) today announced that it has entered into a Sales and Distribution Agreement with Alpha Tech Pet, Inc. Alpha Tech Pet provides innovative solutions for veterinary medical and animal care applications with a full line of detergents, disinfectants and microbial control technologies.
This agreement is another key component of an impressive slate of market leaders that we have strategically aligned ourselves with during the past 4 months. Alpha Tech Pet's direct access to the veterinary community and commercial animal care marketplace, coupled with their leading position in these industries, is a true winning combination for BioNeutral and its customers. YGIENE™ will round out their sterilant/disinfectant offering by adding a high-powered Ready-To-Use sterilant to their already strong product portfolio. Furthermore, Shawn Seitz, DVM, the President and CEO of Alpha Tech Pet, is recognized as an industry expert whom many in the veterinary community, sheltering, animal hospitality and grooming industries look to for recommendations for their sterilization and disinfection protocols. Our YGIENE™ chemistry, proven to kill all microbial life, has gained a significant ally that is directly focused on microbial control in this growing market segment.
"We are delighted to have partnered with BioNeutral in bringing their YGIENE sterilant/disinfectant to the Animal Care marketplace," commented Dr. Shawn Seitz. "YGIENE fills a critical gap for targeting infection reductions and reducing disease transmission in Animal Care facilities. By offering veterinarians and animal care professionals a true surface sterilant/disinfectant, a higher level of disease control is now available for combating infections and reducing communicable diseases. Animal Care Professionals now have an effective means, not previously available, for moving beyond simple disinfection protocols to actual sterilization of surfaces. YGIENE is ideally suited for sterilizing surgical tables, exam tables, grooming tables, tubs, cages, and non-invasive equipment. This product enhances a facility's overall sanitation capability and arms our industry with a much needed additional tool for combating diseases."
"Alpha Tech Pet has a 24 year track record of satisfied customers," said Ray Dunning, Sr. Vice President of Sales for BioNeutral. "If you are a veterinary facility, animal shelter, humane society, pet resort, kennel, aviary, zoo, institution or pet shop you will commonly look to Alpha Tech Pet for their expertise in facility hygiene. Alpha Tech Pet is uniquely positioned to bring our highly effective technology to a whole new set of customers that are committed to reducing infections in the veterinary and animal care marketplace."
About Alpha Tech Pet, Inc.
Alpha Tech Pet, Inc. was founded in Littleton, Massachusetts in 1989 by veterinarian Dr. Shawn Eliot Seitz. With over 29 years of diverse Animal Care Industry experience, Dr. Seitz has utilized his knowledge and experience to develop Alpha Tech Pet's existing line of environmentally sensitive products. Their current product offerings include disinfectants, sanitizers, kennel odor control and cleaning products, drain maintenance, pet laundry items, pumps and containers, and chemical dispensers, all specifically made for the animal care industry. Alpha Tech Pet offers products and the expertise to make facilities cleaner, safer, and more environmentally sensitive. Alpha Tech Pet prides themselves in their innovation, excellence in customer service and extensive industry expertise, and they stand behind all their products to ensure complete customer satisfaction. Find Alpha Tech Pet at www.alphatechpet.com.
About BioNeutral Group, Inc.
Headquartered in Newark, New Jersey, BioNeutral Group, Inc. is a specialty technology-based life-science company that has developed a technology platform that neutralizes harmful environmental contaminants, toxins and dangerous micro-organisms including bacteria, viruses, mold, fungi and spores. BioNeutral's products, YGIENE™ and OGIENE™, kill germs and clean surfaces with a dramatic increase in speed and power over their rivals in the marketplace. BioNeutral's proprietary platform technology has been proven effective in surface, water and airborne applications. Its antimicrobial line of products under the YGIENE™ brand has been approved by the EPA for sale in the United States. For more information on BioNeutral, including a listing of company products, leadership and background please visit www.bioneutral.com.
Find us on Facebook: http://www.facebook.com/pages/BioNeutral-Group/149109938452393
Follow us on Twitter: http://twitter.com/bioneutralgroup
Forward-Looking Statements: This release contains certain "forward-looking statements" relating to the business of the Company and its subsidiary companies. These forward-looking statements are often identified by the use of forward-looking terminology such as "believes," "expects" or similar expressions. Such forward-looking statements involve known and unknown risks and uncertainties that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those described in the Company's filings with the Securities and Exchange Commission. BioNeutral routinely tests its formulations against those of its competitors. The results are published to let shareholders know how the Company's technology compares with known formulations in the market place. Any product claim for antimicrobial activity requires approval from the EPA or FDA, depending upon where and how the formulations are used. The EPA has approved and registered the Company's data and findings specific to Ygiene-206. BioNeutral's antimicrobial formulations will be marketed under the brand name Ygiene® and are available for sale in the United States.
CONTACT INFORMATION
CONTACT FOR THE COMPANY:
Mark Lowenthal
CEO
BioNeutral Group, Inc.
+1-973-577-8003
SOURCE: BioNeutral Group, Inc.
Associated Documentation:
Link to submission on http://www.eteligis.com
BONU_-_03-26-2014_-_LLF_ETL.docx
To unsubscribe from any future mailings, please visit: http://www.eteligis.com/MassMailUnsubscribe.aspx
Copyright eTeligis Inc. 2014. All rights reserved.
0 comments:
Post a Comment